Clinical Trial Update: Intravitreal Ranibizumab Versus Its Combination With Dexamethasone in The Treatment of Diabetic Macular Edema [Phase 3]

View source ↗

Summary

Phase 3 trial comparing intravitreal ranibizumab alone to its combination with dexamethasone for diabetic macular edema has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Dexamethasone (intravitreal) (dexamethasone)
• Ranibizumab (ranibizumab)

Snippet

Sponsor: Cairo University | Conditions: Diabetic Macular Edema | Phase 3 | Status: COMPLETED